SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TEBALDI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.805
AS - Asia 2.100
EU - Europa 1.304
SA - Sud America 397
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.649
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.721
SG - Singapore 914
CN - Cina 557
DE - Germania 372
BR - Brasile 335
HK - Hong Kong 231
IT - Italia 210
FI - Finlandia 187
VN - Vietnam 131
GB - Regno Unito 108
UA - Ucraina 100
TR - Turchia 90
SE - Svezia 70
RU - Federazione Russa 63
FR - Francia 56
ID - Indonesia 51
PL - Polonia 47
MX - Messico 43
CA - Canada 35
IN - India 32
NL - Olanda 28
BD - Bangladesh 20
ZA - Sudafrica 19
AR - Argentina 18
JP - Giappone 18
EC - Ecuador 15
AT - Austria 14
ES - Italia 14
CO - Colombia 11
BE - Belgio 9
IQ - Iraq 9
LT - Lituania 8
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
VE - Venezuela 5
CH - Svizzera 4
IR - Iran 4
KE - Kenya 4
KR - Corea 4
PY - Paraguay 4
CL - Cile 3
EG - Egitto 3
MA - Marocco 3
PH - Filippine 3
SA - Arabia Saudita 3
SN - Senegal 3
AM - Armenia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 7.649
Salva come PNG Salva come JPEG
Città #
Ashburn 544
Singapore 468
Fairfield 387
Woodbridge 310
Munich 250
Hong Kong 229
Beijing 224
Santa Clara 223
Houston 187
Chandler 173
Seattle 138
Wilmington 127
Cambridge 122
Helsinki 112
Jacksonville 112
Ann Arbor 105
Dallas 82
New York 79
Los Angeles 76
Princeton 61
Izmir 51
Jakarta 50
Ho Chi Minh City 47
San Diego 47
Shanghai 46
Warsaw 41
Nanjing 40
Ferrara 39
São Paulo 39
Turku 38
Milan 35
London 31
Hanoi 28
Mexico City 28
Brooklyn 26
Chicago 26
Bremen 19
Buffalo 19
Tokyo 18
Boardman 17
Boston 16
Stockholm 16
Johannesburg 15
Bologna 14
Frankfurt am Main 14
Moscow 14
Chennai 13
Denver 13
Nanchang 13
San Francisco 13
Tianjin 13
Orem 12
Toronto 12
Falls Church 11
Montreal 11
Nuremberg 11
Atlanta 10
Augusta 10
Brussels 9
Dong Ket 9
Jyväskylä 9
Lappeenranta 9
Falkenstein 8
Jiaxing 8
Rio de Janeiro 8
Salt Lake City 8
Shenyang 8
Amsterdam 7
Ankara 7
Charlotte 7
Goiânia 7
Hebei 7
Hefei 7
Norwalk 7
Washington 7
Brasília 6
Campinas 6
Dhaka 6
Mountain View 6
Phoenix 6
Redondo Beach 6
The Dalles 6
Changsha 5
Council Bluffs 5
Ningbo 5
Ninh Bình 5
Osasco 5
Poplar 5
Quito 5
Addison 4
Auburn Hills 4
Belo Horizonte 4
Columbus 4
Curitiba 4
Da Nang 4
Des Moines 4
Guangzhou 4
Guarulhos 4
Haiphong 4
Hangzhou 4
Totale 5.178
Salva come PNG Salva come JPEG
Nome #
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 371
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 252
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 233
Poor response to clopidogrel: current and future options for its management 222
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 208
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 192
Angina and left ventricular dysfunction: can we "reduce' it? 177
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 177
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 174
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 172
Fractional flow reserve: Current applications and overview of the available data 169
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 168
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 165
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 160
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 156
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 154
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 153
Fractional flow reserve implementation in daily clinical practice: A European survey 152
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 149
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) 146
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 145
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 144
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 143
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 142
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 138
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 136
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 136
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 130
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 130
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 125
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 124
Enhanced stent visualization systems during PCI: A case series and review of literature 123
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 121
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 121
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 119
Functional Assessment and Acute Coronary Syndrome 114
Seven french radial artery access for PCI: A prospective single-center experience 112
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 106
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 105
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 105
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 100
null 94
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. 93
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 92
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 92
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 90
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 87
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 84
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 80
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 79
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 75
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 74
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 67
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study 66
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 60
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 59
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 59
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 57
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 55
Low FFR equal to low ischemia: Really? 49
The unbearable lightness of the instantaneous wave-free ratio/fractional flow reserve discordance 40
Totale 7.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021393 0 0 0 0 0 33 25 80 31 90 87 47
2021/2022624 86 57 52 28 21 34 34 43 16 40 66 147
2022/2023471 59 23 36 27 74 62 25 49 66 6 32 12
2023/2024439 24 34 18 15 30 85 23 80 6 15 8 101
2024/20251.981 25 36 130 82 206 219 164 137 369 176 254 183
2025/20262.270 446 213 388 498 662 63 0 0 0 0 0 0
Totale 7.821